This inventor holds 2 USPTO granted patents and 2 published patent applications and 2 EPO patents. Top assignee: Centro De Ingenieria Genetica Y Biotecnologia. Active years: 2013-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2013-2025
Title: Innovations by Yunier Rodriguez Alvarez
Introduction
Yunier Rodriguez Alvarez is a notable inventor based in Havana, Cuba. He has made significant contributions to the field of molecular immunology, particularly through his innovative work on interleukin-15 activity antagonists. With a total of 2 patents, his inventions aim to address critical health issues related to cancer and autoimmune diseases.
Latest Patents
Alvarez's latest patents include the "Interleukin-15 activity antagonist peptide" and the "Peptide antagonist of interleukin-15 activity." The first patent discloses an antagonist peptide characterized by specific amino acid sequences, which can be used in pharmaceutical compositions for treating diseases associated with IL-15 overexpression, such as prostate and kidney cancer. The second patent focuses on a peptide derived from IL-15 that inhibits its biological activity, demonstrating potential therapeutic applications for conditions like rheumatoid arthritis and prostate cancer.
Career Highlights
Yunier Rodriguez Alvarez is affiliated with the Centro de Ingeniería Genética y Biotecnología, where he conducts his research and development. His work has garnered attention for its potential impact on treating serious health conditions, showcasing his commitment to advancing medical science.
Collaborations
Alvarez collaborates with esteemed colleagues, including Hilda Elisa Garay Perez and Osvaldo Reyes Acosta. Their combined expertise contributes to the innovative research being conducted at their institution.
Conclusion
Yunier Rodriguez Alvarez stands out as a prominent inventor in the field of molecular immunology, with his patents reflecting a dedication to improving health outcomes through innovative solutions. His work continues to inspire advancements in medical research and treatment methodologies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
